The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy
- PMID: 25645630
- PMCID: PMC4880465
- DOI: 10.1016/j.seizure.2014.11.008
The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy
Abstract
Purpose: Mesial temporal lobe epilepsy (MTLE) is the most prevalent type of partial epileptic disorders. In this study, we have analyzed the impact of levetiracetam (LEV) in the pilocarpine model of MTLE.
Methods: Sprague-Dawley rats (n=19) were injected with pilocarpine (380 mg/kg, i.p.) to induce a status epilepticus. Twelve animals were used as controls and seven were treated with LEV. They were implanted with bipolar electrodes in the CA3 subfield of the hippocampus, entorhinal cortex (EC), dentate gyrus (DG) and subiculum and EEG-video monitored continuously from day 4 to day 14 after SE.
Results: Only 29% of LEV-treated animals had seizures compared to all controls following a latent period that was similar in duration. Seizure rates were lower in LEV-treated animals. In LEV-treated animals without seizures, lower interictal spike rates were found in all regions compared to controls. Analysis of interictal high-frequency oscillations (HFO s) revealed that LEV-treated animals without seizures had lower rates of interictal spikes with ripples (80-200 Hz) in CA3, EC and subiculum (p<0.01), whereas rates of interictal spikes with fast ripples (250-500 Hz) were significantly lower in CA3 and subiculum, compared to controls.
Conclusion: Our findings indicate that the anti-ictogenic properties of LEV are mirrored by decreases of interictal spike rate in temporal lobe regions, and are accompanied by subregion-specific decreases of HFO occurrence in CA3 and subiculum. Overall, this evidence suggest that LEV may inhibit neural network activity in regions that are known to play important roles in MTLE.
Keywords: High-frequency oscillations; Interictal spikes; Levetiracetam; Pilocarpine; Seizures.
Copyright © 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
M.A. received an investigator initiated grant from UCB Pharma. The remaining authors have no conflict of interest. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
Figures





Similar articles
-
Lacosamide modulates interictal spiking and high-frequency oscillations in a model of mesial temporal lobe epilepsy.Epilepsy Res. 2015 Sep;115:8-16. doi: 10.1016/j.eplepsyres.2015.05.006. Epub 2015 May 19. Epilepsy Res. 2015. PMID: 26220372 Free PMC article.
-
Dynamics of interictal spikes and high-frequency oscillations during epileptogenesis in temporal lobe epilepsy.Neurobiol Dis. 2014 Jul;67:97-106. doi: 10.1016/j.nbd.2014.03.012. Epub 2014 Mar 28. Neurobiol Dis. 2014. PMID: 24686305 Free PMC article.
-
Allopregnanolone decreases interictal spiking and fast ripples in an animal model of mesial temporal lobe epilepsy.Neuropharmacology. 2017 Jul 15;121:12-19. doi: 10.1016/j.neuropharm.2017.04.020. Epub 2017 Apr 15. Neuropharmacology. 2017. PMID: 28416442
-
Evolution of interictal activity in models of mesial temporal lobe epilepsy.Neurobiol Dis. 2023 May;180:106065. doi: 10.1016/j.nbd.2023.106065. Epub 2023 Mar 11. Neurobiol Dis. 2023. PMID: 36907521 Review.
-
High-frequency oscillations and mesial temporal lobe epilepsy.Neurosci Lett. 2018 Feb 22;667:66-74. doi: 10.1016/j.neulet.2017.01.047. Epub 2017 Jan 20. Neurosci Lett. 2018. PMID: 28115239 Review.
Cited by
-
Phase-amplitude coupling and epileptogenesis in an animal model of mesial temporal lobe epilepsy.Neurobiol Dis. 2018 Jun;114:111-119. doi: 10.1016/j.nbd.2018.02.008. Epub 2018 Feb 24. Neurobiol Dis. 2018. PMID: 29486299 Free PMC article.
-
Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model - Phenytoin and Valproate, Lamotrigine and Valproate.PLoS One. 2017 Jan 11;12(1):e0169974. doi: 10.1371/journal.pone.0169974. eCollection 2017. PLoS One. 2017. PMID: 28076384 Free PMC article.
-
The 4-Aminopyridine Model of Acute Seizures in vitro Elucidates Efficacy of New Antiepileptic Drugs.Front Neurosci. 2019 Jun 27;13:677. doi: 10.3389/fnins.2019.00677. eCollection 2019. Front Neurosci. 2019. PMID: 31316344 Free PMC article.
-
Lacosamide and Levetiracetam Have No Effect on Sharp-Wave Ripple Rate.Front Neurol. 2017 Dec 21;8:687. doi: 10.3389/fneur.2017.00687. eCollection 2017. Front Neurol. 2017. PMID: 29312120 Free PMC article.
-
Update on the mechanisms and roles of high-frequency oscillations in seizures and epileptic disorders.Epilepsia. 2017 Aug;58(8):1330-1339. doi: 10.1111/epi.13830. Epub 2017 Jul 6. Epilepsia. 2017. PMID: 28681378 Free PMC article. Review.
References
-
- Lyseng-Williamson KA. Levetiracetam: a review of its use in epilepsy. Drugs. 2011;71(March 4):489–514. - PubMed
-
- Löscher W, Hönack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther. 1998;284(February 2):474–9. - PubMed
-
- Vinogradova LV, van Rijn CM. Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model. Epilepsia. 2008;49(July 7):1160–8. - PubMed
-
- Yan H-D, Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M. Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER) Epilepsia. 2005;46(August 8):1170–7. - PubMed
-
- Sugaya Y, Maru E, Kudo K, Shibasaki T, Kato N. Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus. Brain Res. 2010;1352:187–99. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous